Admin

02/02/2021

Research Scientist (Clinical Development Department) [based in Seoul]

10/12/2018

‘The Euvichol story’ published in Vaccine

“The Euvichol Story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships” spearheaded by the International Vaccine Institute (IVI), has been published in Vaccine by Elsevier. The Euvichol Story published on October 9, 2018 in the […]
10/05/2018

Let’s build a common defense against epidemics

This recent Op-Ed in the Financial News, a leading business daily in Korea, by IVI’s Director General, Dr. Jerome Kim, details the essential nature of pre-emptive vaccine development and the need for global collaboration to prevent epidemics involving certain emerging pathogens. He urges Korea to […]
01/10/2018

세계 최초 플라스틱 튜브형 경구용 콜레라 백신 ‘유비콜-플러스®’ 세계보건 시장 공급 개시

세계 최초 플라스틱 튜브형 경구용 콜레라 백신 ‘유비콜-플러스®’ 세계보건 시장 공급 개시 – 유바이오로직스의 새로운 경구용 콜레라 백신, 지난해 8월 WHO 사전적격성 평가 인증 획득 후 잠비아와 소말리아로 첫 출하 – 혁신적 포장으로 백신 단가 낮추고 사용 편의성 향상 – 세계시장 공급을 위해 연간 5,000만 […]